89Zr-RO5323441
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 89Zr-RO5323441, covering 2024-05-06 to 2024-05-06. Get the full timeline:
Most recent: Clinical Trial Update: 89Zr-RO5323441 PET Imaging in Glioblastoma [Phase 2]